Harvard Bioscience (HBIO) Change in Cash (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Change in Cash data on file, last reported at -$1.5 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 205.42% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 20.22% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 2674.86% from the prior year.
• Change in Cash for Q1 2026 stood at -$1.5 million, down from $1.8 million in the prior quarter.
• Over the last five years, Change in Cash for HBIO reached as high as $1.9 million in Q2 2025 and fell as low as -$2.4 million in Q1 2022.
• Historically, Change in Cash has averaged -$42529.4 across 5 years, with a median of -$207000.0 in 2024.
• Across the five-year window, Change in Cash slumped 378.2% in 2022 and soared 5235.71% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$636000.0 in 2022, then tumbled by 66.19% to -$1.1 million in 2023, then soared by 56.39% to -$461000.0 in 2024, then surged by 489.8% to $1.8 million in 2025, then plunged by 184.36% to -$1.5 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$1.5 million in Q1 2026, $1.8 million in Q4 2025, and -$625000.0 in Q3 2025.